[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355773-105":59,"doc-detail-355773-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","catabolism-of-extracellular-glutathione-supplies-cysteine-to-support-tumours","Catabolism of extracellular glutathione supplies cysteine to support tumours","","Glutathione (GSH), a cysteine-containing tripeptide, is typically viewed as an intracellular antioxidant with tumor-promoting effects, yet its extracellular catabolism may provide essential amino acids. This article demonstrates that depleting intracellular GSH does not change tumour growth, while extracellular GSH is abundant in the tumour microenvironment. Adding GSH rescues cancer survival and growth under cystine-deficient conditions via γ-glutamyltransferase catabolism. Pharmacological inhibition blocks circulating GSH breakdown, lowers tumour cysteine, and slows tumour growth, supporting a reservoir-based, non-canonical role for extracellular GSH in amino-acid supply and therapeutic targeting.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/catabolism-of-extracellular-glutathione-supplies-cysteine-to-support-tumours/355773/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/catabolism-of-extracellular-glutathione-supplies-cysteine-to-support-tumours/355773.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Does intracellular glutathione depletion affect tumour growth?","Question",{"text":113,"@type":114},"Depleting intracellular GSH does not alter tumour growth in the reported findings.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does extracellular GSH support cancer cells under cystine-deficient conditions?",{"text":118,"@type":114},"Supplementation with GSH rescues cancer cell survival and growth in cystine-deficient settings, depending on γ-glutamyltransferase catabolic activity.",{"name":120,"@type":111,"acceptedAnswer":121},"What happens when γ-glutamyltransferase activity is pharmacologically targeted?",{"text":122,"@type":114},"Inhibiting γ-glutamyltransferases prevents circulating GSH breakdown, reduces tumour cysteine levels, and slows tumour growth.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355773,1790468852,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \n\n| Catabolism of extracellular glutathione supplies cysteineto support tumours |  |  |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s41586-026-10268-2](https://doi.org/10.1038/s41586-026-10268-2) | Fabio Hecht1,2,14✉, Marco Zocchi1,2,14, Emily T. Tuttle1,2, Nathan P. Ward3,\u003Cbr>Fatemeh Alimohammadi1,2, Amal Afzal Khan1,4, Veronica C. Gomes1,2, Bradley Smith2, Jennifer J. Twardowski2, Bradley N. Mills2,5, Kevin A. Welle6, Sina Ghaemmaghami6,7, Zhuoran Zhou1, Yuhan Gan1, Yun Pyo Kang3, Juliana Cazarin1,2, Zamira G. Soares1,2,\u003Cbr>Mete Emir Ozgurses8, Huiping Zhao8, Colin Sheehan9, Guillaume Cognet9, Lila D. Munger1,2, Dhvani Trivedi1,2, Gloria Asantewaa1,2,10, Sara K. Blick-Nitko1,2, Jason J. Zoeller11, Ying Chen12, Vasilis Vasiliou12, Bradley M. Turner4, Stephano S. Mello1,2, Brian J. Altman1,2, Alexander Muir9, Jonathan L. Coloff8, Joshua Munger2,10, Gina M. DeNicola3 & Isaac S. Harris1,2,13 ✉\u003Cbr>Restricting amino acids from tumours isan emerging therapeutic strategy with substantial promise1. Although typically considered an intracellular antioxidant with tumour-promoting capabilities2, glutathione (GSH), asa tripeptide of cysteine, glutamate and glycine, can becatabolized to release amino acids. The extent to which GSH-derived amino acids are essential to cancers is unclear. Here we show that depletion of intracellular GSH does not alter tumour growth and extracellular GSHis highly abundant in the tumour microenvironment, highlighting the potential importance of GSH outside tumours. Supplementation with GSH rescues cancer cell survival and growth incystine-deficient conditions, and this rescue depends on thecatabolic activity of γ-glutamyltransferases. Finally, pharmacological targeting of the activity of γ-glutamyltransferases prevents the breakdown of circulating GSH, reduces tumour cysteine levels and slows tumour growth. Our findings indicate anon-canonical role for GSHin supporting tumours by acting asa reservoir of amino acids. Depriving tumours of extracellular GSHor inhibiting its breakdown is potentially a therapeutically tractable approach for patients with cancer. Furthermore, these findings change our view of GSHand how amino acids, including cysteine, are supplied to cells. |  |\n| Received: 30 September 2024 |  |  |\n| Accepted: 11 February 2026 |  |  |\n| Published online: 18 March 2026 |  |  |\n| Open access |  |  |\n|  Check for updates |  |  |\n| Amino acids are crucial for cancer initiation, progression and drug |  | through system xc − is thought tobe the predominant source of cysteine |\n| resistance3. Despite their indispensability, amino acids are often scarce |  | in cancer cells14. Notably, the deletion ofSlc7a11 (which encodes xCT) |\n| in the tumour microenvironment4, which drives tumours to develop strategies to import and synthesize them5–7. Thus, interfering with |  | in animals results in viable offspring15, which suggests that tissues (and potentially tumours) can obtain cysteine from another origin. The |\n| these mechanismsand restricting amino acid access holds potential as |  | generation of cysteine from the transsulfuration pathway is a potential |\n| an anticancer strategy1. One amino acid that has garnered substantial |  | source. However, this pathway is reported tobe inactive inmost tissues, |\n| attention as an anticancer target is cysteine8,9. Beyond being a build- |  | and in the few tissues in which it is active, its function is reduced in |\n| ing block for proteins, cysteine has roles that include supporting the |  | tumours from the corresponding tissue16. Together, these results sug- |\n| generation of antioxidants (for example, glutathione and persulfide species)10, metabolites (for example, H2S, CoA and hypotaurine)11,12 and |  | gest that tumours have an alternative mechanism to acquire cysteine. GSHisan antioxidant that regulates oxidative stress, drug detoxifica- |\n| iron–sulfur clusters for mitochondria13. The intracellular cysteine pool |  | tion and post-translational mo","cbCairuZusqTVWzc","https://ap.wps.com/l/cbCairuZusqTVWzc","pdf",40128856,36,"English","# Main findings\n## GSH depletion and tumour growth\n## Extracellular GSH as a cysteine reservoir\n## Therapeutic targeting of γ-glutamyltransferases","[{\"question\":\"Does intracellular glutathione depletion affect tumour growth?\",\"answer\":\"Depleting intracellular GSH does not alter tumour growth in the reported findings.\"},{\"question\":\"How does extracellular GSH support cancer cells under cystine-deficient conditions?\",\"answer\":\"Supplementation with GSH rescues cancer cell survival and growth in cystine-deficient settings, depending on γ-glutamyltransferase catabolic activity.\"},{\"question\":\"What happens when γ-glutamyltransferase activity is pharmacologically targeted?\",\"answer\":\"Inhibiting γ-glutamyltransferases prevents circulating GSH breakdown, reduces tumour cysteine levels, and slows tumour growth.\"}]","Catabolism of extracellular glutathione supplies cysteine to support tumours | PDF",1790120878,91,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7dae57fa55373f29c479908a609f64a0.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e9f63817298d9c4da408e40f7c7403c.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/506d95f8c17deb0c5ec49a579f988797.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45b2660c1fcc2c5834278c8cc9cf55d9.webp",980,1301]